These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10759723)

  • 1. Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice.
    Ballen K; Becker PS; Greiner D; Valinski H; Shearin D; Berrios V; Dooner G; Hsieh CC; Wuu J; Shultz L; Cerny J; Leif J; Stewart FM; Quesenberry P
    Br J Haematol; 2000 Mar; 108(3):629-40. PubMed ID: 10759723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
    Du Z; Jin H; Cai H; Yang S; Tan WS
    Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
    Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
    Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
    Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
    Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts.
    Peters SO; Kittler EL; Ramshaw HS; Quesenberry PJ
    Blood; 1996 Jan; 87(1):30-7. PubMed ID: 8547656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematopoietic reconstitution of fresh and cultured cord blood CD34+ cells in NOD/SCID mice].
    Yang S; Cai HB; Jin HL; Tan WS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):947-9. PubMed ID: 18845075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual and synergistic cytokine effects controlling the expansion of cord blood CD34(+) cells and megakaryocyte progenitors in culture.
    Pineault N; Cortin V; Boyer L; Garnier A; Robert A; Thérien C; Roy DC
    Cytotherapy; 2011 Apr; 13(4):467-80. PubMed ID: 21090916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion and engraftment potential of cord blood-derived CD34+ cells in NOD/SCID mice.
    Fibbe WE; Noort WA; Schipper F; Willemze R
    Ann N Y Acad Sci; 2001 Jun; 938():9-17. PubMed ID: 11458530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.
    Albella B; Segovia JC; Guenechea G; Pragnell IB; Bueren JA
    Transplantation; 1999 May; 67(10):1348-57. PubMed ID: 10360589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice.
    Peled T; Landau E; Mandel J; Glukhman E; Goudsmid NR; Nagler A; Fibach E
    Exp Hematol; 2004 Jun; 32(6):547-55. PubMed ID: 15183895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells.
    Piacibello W; Gammaitoni L; Bruno S; Gunetti M; Fagioli F; Cavalloni G; Aglietta M
    J Hematother Stem Cell Res; 2000 Dec; 9(6):945-56. PubMed ID: 11177609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged ex vivo culture of cord blood CD34(+) cells facilitates myeloid and megakaryocytic engraftment in the non-obese diabetic severe combined immunodeficient mouse model.
    Rice AM; Wood JA; Milross CG; Collins CJ; Case J; Vowels MR; Nordon RE
    Br J Haematol; 2001 Aug; 114(2):433-43. PubMed ID: 11529868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Engraftment of ex vivo expanded mononuclear cells from human umbilical cord blood in NOD/SCID mice].
    Xu L; Lin JY; Mao P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1243-6. PubMed ID: 18088476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
    Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
    Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.